Is Forte Biosciences Stock a Good Investment?
Forte Biosciences Investment Advice | FBRX |
- Examine Forte Biosciences' financial health by looking at its balance sheet, income statement, and cash flow statement. Analyze key financial ratios, such as Price-to-Earnings (P/E), Price-to-Sales (P/S), and Price-to-Book (P/B), to determine whether the stock is fairly valued or over/undervalued.
- Research Forte Biosciences' leadership team and their track record. Good management can help Forte Biosciences navigate difficult times and make strategic decisions that benefit shareholders and increases its net worth.
- Consider the overall health of the Biotechnology space and any emerging trends that could impact Forte Biosciences' business and its evolving consumer preferences.
- Compare Forte Biosciences' performance and market position to its competitors. Analyze how Forte Biosciences is positioned in terms of product offerings, innovation, and market share.
- Check if Forte Biosciences pays a dividend and its dividend yield and payout ratio.
- Review what financial analysts are saying about Forte Biosciences' stock and their price targets. However, remember that analysts' opinions can vary, and their predictions may not always be accurate.
It's important to note that investing in Forte Biosciences stock, carries risks, and you should carefully consider your investment goals and risk tolerance before making any investment decisions. Also, remember that it's important for investors to have a long-term perspective and a well-diversified portfolio to manage the impact of stock market volatility on their investments. Below is a detailed guide on how to decide if Forte Biosciences is a good investment.
Sell | Buy |
Cautious Hold
Market Performance | Good | Details | |
Volatility | Unstable | Details | |
Hype Condition | Stale | Details | |
Current Valuation | Fairly Valued | Details | |
Odds Of Distress | Low | Details | |
Economic Sensitivity | Responds to the market | Details | |
Investor Sentiment | Impartial | Details | |
Analyst Consensus | Not Available | Details | |
Financial Leverage | Not Rated | Details | |
Reporting Quality (M-Score) | Unavailable | Details |
Examine Forte Biosciences Stock
Researching Forte Biosciences' stock involves analyzing various aspects of the company and its industry to make an informed investment decision. The key areas to focus on are fundamentals, business model and competitive advantage. It is also important to analyze trends in revenue, net income, and cash flow, as well as key financial ratios, such as price-to-earnings (P/E), price-to-sales (P/S), and debt-to-equity (D/E). About 54.0% of the company shares are owned by institutional investors. The company recorded a loss per share of 16.31. Forte Biosciences last dividend was issued on the 16th of June 2020. The entity had 1:25 split on the 28th of August 2024.
To determine if Forte Biosciences is a good investment, evaluating the company's potential for future growth is also very important. This may include expanding into new markets, launching new products or services, or improving operational efficiency. Companies with strong growth prospects can be more attractive investments. This aspect of the research should be conducted in the context of the overall market and industry in which the company operates and should include an analysis of growth potential, competitive landscape, and any regulatory or economic factors that could impact the business. Some of the essential points regarding Forte Biosciences' research are outlined below:
| Forte Biosciences is way too risky over 90 days horizon | |
| Forte Biosciences appears to be risky and price may revert if volatility continues | |
| Net Loss for the year was (31.48 M) with profit before overhead, payroll, taxes, and interest of 0. | |
| Forte Biosciences currently holds about 38.55 M in cash with (28.71 M) of positive cash flow from operations. This results in cash-per-share (CPS) ratio of 1.89. |
Forte Biosciences uses earnings reports to provide investors with an update of all three financial statements, including the income statement, the balance sheet, and the cash flow statement. Therefore, it is also crucial when considering investing in Forte Biosciences. Every quarterly earnings report provides investors with an overview of sales, expenses, and net income for the most recent period. It also may provide a comparison to Forte Biosciences' previous reporting period. The quarterly earnings reports are usually disseminated to the public via Form 10-Q, which is a legal document filed with the Securities and Exchange Commission every quarter.
| 29th of March 2024 Upcoming Quarterly Report | View | |
| 20th of May 2024 Next Financial Report | View | |
| 31st of December 2023 Next Fiscal Quarter End | View | |
| 29th of March 2024 Next Fiscal Year End | View | |
| 30th of September 2023 Last Quarter Report | View | |
| 31st of December 2022 Last Financial Announcement | View |
Forte Biosciences' market capitalization trends
The company currently falls under 'Small-Cap' category with a current market capitalization of 102.04 M.Basic technical analysis of Forte Stock
As of the 2nd of February, Forte Biosciences shows the Downside Deviation of 6.46, coefficient of variation of 571.02, and Mean Deviation of 7.98. Forte Biosciences technical analysis allows you to utilize historical prices and volume patterns in order to determine a pattern that computes the direction of the firm's future prices.Forte Biosciences' insider trading activities
Some recent studies suggest that insider trading raises the cost of capital for securities issuers and decreases overall economic growth. Trading by specific Forte Biosciences insiders, such as employees or executives, is commonly permitted as long as it does not rely on Forte Biosciences' material information that is not in the public domain. Local jurisdictions usually require such trading to be reported in order to monitor insider transactions. In many U.S. states, trading conducted by corporate officers, key employees, directors, or significant shareholders must be reported to the regulator or publicly disclosed, usually within a few business days of the trade. In these cases Forte Biosciences insiders are required to file a Form 4 with the U.S. Securities and Exchange Commission (SEC) when buying or selling shares of their own companies.
Forte Biosciences' Outstanding Corporate Bonds
Forte Biosciences issues bonds to finance its operations. Corporate bonds make up one of the largest components of the U.S. bond market, which is considered the world's largest securities market. Forte Biosciences uses the proceeds from bond sales for a wide variety of purposes, including financing ongoing mergers and acquisitions, buying new equipment, investing in research and development, buying back their own stock, paying dividends to shareholders, and even refinancing existing debt. Most Forte bonds can be classified according to their maturity, which is the date when Forte Biosciences has to pay back the principal to investors. Maturities can be short-term, medium-term, or long-term (more than ten years). Longer-term bonds usually offer higher interest rates but may entail additional risks.
| Dana 575 percent Corp BondUS235822AB96 | View | |
| FORTUNE BRANDS HOME Corp BondUS34964CAA45 | View | |
| US34964CAE66 Corp BondUS34964CAE66 | View | |
| FBINUS 45 25 MAR 52 Corp BondUS34964CAG15 | View | |
| FBINUS 4 25 MAR 32 Corp BondUS34964CAF32 | View | |
| HSBC Holdings PLC Corp BondUS404280DR76 | View | |
| US34960PAD33 Corp BondUS34960PAD33 | View | |
| MPLX LP 4125 Corp BondUS55336VAK61 | View |
Understand Forte Biosciences' technical and predictive indicators
Using predictive indicators to make investment decisions involves analyzing Forte Biosciences' various financial and market-based factors to help forecast future trends and identify investment opportunities. Select the indicators that are most relevant to your investment strategy. Each indicator has its own strengths and weaknesses, so it's essential to combine multiple indicators to get a more comprehensive view of the market and reduce the risk of making poor decisions based on limited data.
| Risk Adjusted Performance | 0.1564 | |||
| Market Risk Adjusted Performance | 2.21 | |||
| Mean Deviation | 7.98 | |||
| Semi Deviation | 5.36 | |||
| Downside Deviation | 6.46 | |||
| Coefficient Of Variation | 571.02 | |||
| Standard Deviation | 17.79 | |||
| Variance | 316.65 | |||
| Information Ratio | 0.1707 | |||
| Jensen Alpha | 3.01 | |||
| Total Risk Alpha | 1.65 | |||
| Sortino Ratio | 0.47 | |||
| Treynor Ratio | 2.2 | |||
| Maximum Drawdown | 146.6 | |||
| Value At Risk | (8.62) | |||
| Potential Upside | 14.1 | |||
| Downside Variance | 41.77 | |||
| Semi Variance | 28.76 | |||
| Expected Short fall | (10.62) | |||
| Skewness | 5.97 | |||
| Kurtosis | 42.34 |
| Risk Adjusted Performance | 0.1564 | |||
| Market Risk Adjusted Performance | 2.21 | |||
| Mean Deviation | 7.98 | |||
| Semi Deviation | 5.36 | |||
| Downside Deviation | 6.46 | |||
| Coefficient Of Variation | 571.02 | |||
| Standard Deviation | 17.79 | |||
| Variance | 316.65 | |||
| Information Ratio | 0.1707 | |||
| Jensen Alpha | 3.01 | |||
| Total Risk Alpha | 1.65 | |||
| Sortino Ratio | 0.47 | |||
| Treynor Ratio | 2.2 | |||
| Maximum Drawdown | 146.6 | |||
| Value At Risk | (8.62) | |||
| Potential Upside | 14.1 | |||
| Downside Variance | 41.77 | |||
| Semi Variance | 28.76 | |||
| Expected Short fall | (10.62) | |||
| Skewness | 5.97 | |||
| Kurtosis | 42.34 |
Consider Forte Biosciences' intraday indicators
Forte Biosciences intraday indicators are useful technical analysis tools used by many experienced traders. Just like the conventional technical analysis, daily indicators help intraday investors to analyze the price movement with the timing of Forte Biosciences stock daily movement. By combining multiple daily indicators into a single trading strategy, you can limit your risk while still earning strong returns on your managed positions.
Forte Biosciences time-series forecasting models is one of many Forte Biosciences' stock analysis techniques aimed to predict future share value based on previously observed values. Time-series forecasting models ae widely used for non-stationary data. Non-stationary data are called the data whose statistical properties e.g. the mean and standard deviation are not constant over time but instead, these metrics vary over time. These non-stationary Forte Biosciences' historical data is usually called time-series. Some empirical experimentation suggests that the statistical forecasting models outperform the models based exclusively on fundamental analysis to predict the direction of the market movement and maximize returns from investment trading.
Forte Stock media impact
Far too much social signal, news, headlines, and media speculation about Forte Biosciences that are available to investors today. That information is available publicly through Forte media outlets and privately through word of mouth or via Forte internal channels. However, regardless of the origin, that massive amount of Forte data is challenging to quantify into actionable patterns, especially for investors that are not very sophisticated with ever-evolving tools and techniques used in the investment management field.
A primary focus of Forte Biosciences news analysis is to determine if its current price reflects all relevant headlines and social signals impacting the current market conditions. A news analyst typically looks at the history of Forte Biosciences relative headlines and hype rather than examining external drivers such as technical or fundamental data. It is believed that price action tends to repeat itself due to investors' collective, patterned thinking related to Forte Biosciences' headlines and news coverage data. This data is often completely overlooked or insufficiently analyzed for actionable insights to drive Forte Biosciences alpha.
Additional Tools for Forte Stock Analysis
When running Forte Biosciences' price analysis, check to measure Forte Biosciences' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Forte Biosciences is operating at the current time. Most of Forte Biosciences' value examination focuses on studying past and present price action to predict the probability of Forte Biosciences' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Forte Biosciences' price. Additionally, you may evaluate how the addition of Forte Biosciences to your portfolios can decrease your overall portfolio volatility.